Concepts (143)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Complex Regional Pain Syndromes | 5 | 2022 | 14 | 2.000 |
Why?
|
| Cytokines | 3 | 2022 | 2836 | 0.950 |
Why?
|
| Fibromyalgia | 3 | 2017 | 14 | 0.760 |
Why?
|
| Low Back Pain | 3 | 2013 | 86 | 0.560 |
Why?
|
| Facial Pain | 1 | 2015 | 20 | 0.530 |
Why?
|
| Persian Gulf Syndrome | 1 | 2015 | 15 | 0.520 |
Why?
|
| Stress, Psychological | 3 | 2015 | 1043 | 0.520 |
Why?
|
| Monitoring, Immunologic | 1 | 2015 | 47 | 0.520 |
Why?
|
| Anxiety | 3 | 2015 | 1235 | 0.520 |
Why?
|
| Statistics as Topic | 2 | 2015 | 450 | 0.500 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2014 | 76 | 0.460 |
Why?
|
| Immunoassay | 1 | 2013 | 214 | 0.420 |
Why?
|
| Pain Management | 2 | 2015 | 717 | 0.400 |
Why?
|
| Specimen Handling | 1 | 2013 | 311 | 0.390 |
Why?
|
| Depression | 3 | 2015 | 1736 | 0.380 |
Why?
|
| Inflammation Mediators | 1 | 2013 | 409 | 0.360 |
Why?
|
| Whiplash Injuries | 1 | 2010 | 3 | 0.360 |
Why?
|
| Patient Care Team | 1 | 2015 | 826 | 0.350 |
Why?
|
| Hypesthesia | 1 | 2010 | 22 | 0.350 |
Why?
|
| Neck Pain | 1 | 2010 | 41 | 0.350 |
Why?
|
| Affect | 1 | 2011 | 305 | 0.340 |
Why?
|
| Neural Stem Cells | 2 | 2021 | 184 | 0.330 |
Why?
|
| Chronic Pain | 3 | 2018 | 262 | 0.290 |
Why?
|
| Wrist Injuries | 2 | 2018 | 12 | 0.290 |
Why?
|
| Brain | 2 | 2021 | 4257 | 0.260 |
Why?
|
| Depressive Disorder | 1 | 2010 | 566 | 0.260 |
Why?
|
| Pain | 4 | 2022 | 1696 | 0.260 |
Why?
|
| Neuronal Ceroid-Lipofuscinoses | 1 | 2023 | 17 | 0.220 |
Why?
|
| Pain Measurement | 4 | 2015 | 1018 | 0.220 |
Why?
|
| Cosmic Radiation | 1 | 2022 | 15 | 0.210 |
Why?
|
| Severity of Illness Index | 3 | 2019 | 4399 | 0.200 |
Why?
|
| Neurogenesis | 2 | 2021 | 240 | 0.200 |
Why?
|
| Radiation Exposure | 1 | 2022 | 74 | 0.190 |
Why?
|
| Radiation Protection | 1 | 2022 | 205 | 0.190 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2021 | 92 | 0.190 |
Why?
|
| Space Flight | 1 | 2022 | 136 | 0.180 |
Why?
|
| Stem Cell Niche | 1 | 2021 | 94 | 0.180 |
Why?
|
| Quality of Life | 1 | 2014 | 4732 | 0.180 |
Why?
|
| Antigens, Differentiation | 1 | 2021 | 254 | 0.180 |
Why?
|
| Case-Control Studies | 2 | 2022 | 6027 | 0.170 |
Why?
|
| Suppressor of Cytokine Signaling 3 Protein | 1 | 2019 | 24 | 0.170 |
Why?
|
| Neutrophil Activation | 1 | 2019 | 35 | 0.170 |
Why?
|
| Hand Bones | 1 | 2018 | 8 | 0.160 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2019 | 98 | 0.160 |
Why?
|
| Cytoskeletal Proteins | 1 | 2021 | 542 | 0.160 |
Why?
|
| Chronic Disease | 4 | 2011 | 1851 | 0.160 |
Why?
|
| Membrane Glycoproteins | 1 | 2023 | 1107 | 0.160 |
Why?
|
| Fractures, Bone | 1 | 2018 | 312 | 0.130 |
Why?
|
| Hand Injuries | 1 | 2015 | 18 | 0.130 |
Why?
|
| Cerebellum | 1 | 2019 | 476 | 0.130 |
Why?
|
| Progesterone | 1 | 2017 | 731 | 0.120 |
Why?
|
| Hippocampus | 1 | 2021 | 976 | 0.120 |
Why?
|
| Neutrophils | 1 | 2019 | 870 | 0.120 |
Why?
|
| Demography | 1 | 2015 | 435 | 0.120 |
Why?
|
| Reactive Oxygen Species | 1 | 2019 | 1011 | 0.120 |
Why?
|
| Disabled Persons | 1 | 2015 | 113 | 0.110 |
Why?
|
| Humans | 20 | 2023 | 270947 | 0.110 |
Why?
|
| Physical Therapy Specialty | 1 | 2013 | 6 | 0.110 |
Why?
|
| Freezing | 1 | 2013 | 61 | 0.110 |
Why?
|
| Chemokine CCL4 | 1 | 2013 | 68 | 0.110 |
Why?
|
| Naltrexone | 1 | 2014 | 99 | 0.110 |
Why?
|
| Nerve Tissue Proteins | 1 | 2021 | 1574 | 0.110 |
Why?
|
| Blister | 1 | 2013 | 31 | 0.110 |
Why?
|
| Somatosensory Cortex | 1 | 2013 | 73 | 0.110 |
Why?
|
| Analgesics | 1 | 2015 | 408 | 0.100 |
Why?
|
| Acute Pain | 1 | 2013 | 48 | 0.100 |
Why?
|
| Motor Cortex | 1 | 2013 | 127 | 0.100 |
Why?
|
| Testosterone | 1 | 2017 | 733 | 0.100 |
Why?
|
| Surveys and Questionnaires | 4 | 2013 | 5904 | 0.100 |
Why?
|
| Self Efficacy | 1 | 2013 | 298 | 0.100 |
Why?
|
| Cohort Studies | 2 | 2022 | 9433 | 0.100 |
Why?
|
| Prospective Studies | 3 | 2022 | 13352 | 0.100 |
Why?
|
| Logistic Models | 1 | 2018 | 3437 | 0.090 |
Why?
|
| Pain Clinics | 1 | 2010 | 18 | 0.090 |
Why?
|
| Young Adult | 5 | 2017 | 22059 | 0.090 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2014 | 459 | 0.090 |
Why?
|
| Models, Psychological | 1 | 2011 | 179 | 0.090 |
Why?
|
| Appointments and Schedules | 1 | 2010 | 98 | 0.090 |
Why?
|
| Male | 9 | 2018 | 128454 | 0.080 |
Why?
|
| Middle Aged | 8 | 2018 | 90021 | 0.080 |
Why?
|
| Neuronal Plasticity | 1 | 2010 | 326 | 0.070 |
Why?
|
| Female | 9 | 2018 | 148509 | 0.070 |
Why?
|
| Reproducibility of Results | 2 | 2013 | 6172 | 0.070 |
Why?
|
| Cerebral Cortex | 1 | 2010 | 637 | 0.070 |
Why?
|
| Clinical Laboratory Techniques | 1 | 1987 | 207 | 0.070 |
Why?
|
| Patient Education as Topic | 1 | 2010 | 750 | 0.060 |
Why?
|
| Australia | 2 | 2018 | 249 | 0.060 |
Why?
|
| Adult | 6 | 2018 | 81555 | 0.060 |
Why?
|
| Veterans | 1 | 2015 | 1764 | 0.060 |
Why?
|
| Receptor, IGF Type 2 | 1 | 2023 | 15 | 0.060 |
Why?
|
| Disability Evaluation | 2 | 2015 | 243 | 0.050 |
Why?
|
| Moon | 1 | 2022 | 13 | 0.050 |
Why?
|
| Hydrolases | 1 | 2023 | 132 | 0.050 |
Why?
|
| Molecular Chaperones | 1 | 2023 | 269 | 0.050 |
Why?
|
| Lysosomes | 1 | 2023 | 347 | 0.050 |
Why?
|
| Biology | 1 | 2021 | 76 | 0.040 |
Why?
|
| Adult Stem Cells | 1 | 2021 | 69 | 0.040 |
Why?
|
| Data Interpretation, Statistical | 2 | 2013 | 475 | 0.040 |
Why?
|
| Adolescent | 3 | 2017 | 32577 | 0.040 |
Why?
|
| Myelin-Oligodendrocyte Glycoprotein | 1 | 2019 | 42 | 0.040 |
Why?
|
| Models, Animal | 1 | 2021 | 675 | 0.040 |
Why?
|
| Likelihood Functions | 1 | 2017 | 221 | 0.040 |
Why?
|
| Autophagy | 1 | 2023 | 920 | 0.040 |
Why?
|
| Aged | 4 | 2017 | 73161 | 0.030 |
Why?
|
| Cognitive Dysfunction | 1 | 2021 | 328 | 0.030 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2019 | 770 | 0.030 |
Why?
|
| Proteomics | 1 | 2023 | 1435 | 0.030 |
Why?
|
| Animals | 4 | 2022 | 62771 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2019 | 1212 | 0.030 |
Why?
|
| Mice | 3 | 2021 | 35992 | 0.030 |
Why?
|
| Linear Models | 1 | 2017 | 1093 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2019 | 1329 | 0.030 |
Why?
|
| Publication Bias | 1 | 2013 | 37 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 4371 | 0.030 |
Why?
|
| Aging | 1 | 2021 | 1576 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2019 | 1158 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2019 | 3083 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 1 | 2019 | 1146 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2017 | 2048 | 0.030 |
Why?
|
| Neuroglia | 1 | 2014 | 251 | 0.020 |
Why?
|
| Proprioception | 1 | 2010 | 21 | 0.020 |
Why?
|
| Models, Organizational | 1 | 2010 | 75 | 0.020 |
Why?
|
| Pain Threshold | 1 | 2010 | 133 | 0.020 |
Why?
|
| Neurons | 1 | 2021 | 2465 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2015 | 1150 | 0.020 |
Why?
|
| Patients' Rooms | 1 | 1987 | 13 | 0.020 |
Why?
|
| New Zealand | 1 | 1987 | 65 | 0.020 |
Why?
|
| Outpatients | 1 | 2010 | 470 | 0.020 |
Why?
|
| Health Status | 1 | 2010 | 627 | 0.020 |
Why?
|
| Glucose | 1 | 2013 | 1249 | 0.020 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 1987 | 98 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2010 | 686 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 7461 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2010 | 917 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 4505 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2010 | 935 | 0.020 |
Why?
|
| Delivery of Health Care | 1 | 2010 | 869 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2019 | 12206 | 0.010 |
Why?
|
| Prognosis | 1 | 2018 | 22458 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2013 | 7951 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 15253 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2013 | 39694 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2010 | 33827 | 0.010 |
Why?
|